Correlation Between Protara Therapeutics and Codiak BioSciences

Can any of the company-specific risk be diversified away by investing in both Protara Therapeutics and Codiak BioSciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Protara Therapeutics and Codiak BioSciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Protara Therapeutics and Codiak BioSciences, you can compare the effects of market volatilities on Protara Therapeutics and Codiak BioSciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Protara Therapeutics with a short position of Codiak BioSciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Protara Therapeutics and Codiak BioSciences.

Diversification Opportunities for Protara Therapeutics and Codiak BioSciences

0.0

Correlation Coefficient

Protara Therapeutics  Codiak BioSciences

Pay attention - limited upside

The 3 months correlation between Protara and Codiak is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Protara Therapeutics and Codiak BioSciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Codiak BioSciences and Protara Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Protara Therapeutics are associated (or correlated) with Codiak BioSciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Codiak BioSciences has no effect on the direction of Protara Therapeutics i.e., Protara Therapeutics and Codiak BioSciences go up and down completely randomly.

Pair Corralation between Protara Therapeutics and Codiak BioSciences

If you would invest  192.00  in Protara Therapeutics on September 1, 2024 and sell it today you would earn a total of  109.00  from holding Protara Therapeutics or generate 56.77% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

Protara Therapeutics  vs.  Codiak BioSciences

Protara Therapeutics

Risk-Adjusted Performance

14 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Protara Therapeutics are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Protara Therapeutics sustained solid returns over the last few months and may actually be approaching a breakup point.

Codiak BioSciences

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Codiak BioSciences has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable forward-looking signals, Codiak BioSciences is not utilizing all of its potentials. The newest stock price agitation, may contribute to short-term losses for the retail investors.

Pair Trading with Protara Therapeutics and Codiak BioSciences

The main advantage of trading using opposite Protara Therapeutics and Codiak BioSciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Protara Therapeutics position performs unexpectedly, Codiak BioSciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Codiak BioSciences will offset losses from the drop in Codiak BioSciences' long position.

The idea behind Protara Therapeutics and Codiak BioSciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.